These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38383679)

  • 21. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study.
    Muhsen K; Anis E; Rubinstein U; Kassem E; Goren S; Shulman LM; Ephros M; Cohen D
    Clin Microbiol Infect; 2018 Jan; 24(1):53-59. PubMed ID: 28442435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
    Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of rotavirus vaccination in Australian children below 5 years of age: a database study.
    Pendleton A; Galic M; Clarke C; Ng SP; Ledesma E; Ramakrishnan G; Liu Y
    Hum Vaccin Immunother; 2013 Aug; 9(8):1617-25. PubMed ID: 23733041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for Five Years After Universal RotaTeq Vaccination in Finland.
    Hemming-Harlo M; Markkula J; Huhti L; Salminen M; Vesikari T
    Pediatr Infect Dis J; 2016 Dec; 35(12):1304-1308. PubMed ID: 27455440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The changes of the epidemiology and clinical characteristics of rotavirus gastroenteritis-associated convulsion after the introduction of rotavirus vaccine.
    Kawase M; Hoshina T; Yoneda T; Kojiro M; Takahashi Y; Kusuhara K
    J Infect Chemother; 2020 Mar; 26(3):206-210. PubMed ID: 31563335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal trends in hospitalization for rotavirus gastroenteritis: A nationwide study in Italy, 2005-2012.
    Mattei A; Sbarbati M; Fiasca F; Angelone AM; Mazzei MC; di Orio F
    Hum Vaccin Immunother; 2016; 12(2):534-9. PubMed ID: 26337458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Socioeconomic Impact of the Rotavirus Vaccine in Korea: Comparing the Epidemiologic and Economic Characteristics of Rotavirus Gastroenteritis Before and After the Introduction of Vaccines.
    Cho H; Lee H; Kim DS; Kim HM; Kim JH; Kim AY; Kang HY
    Pediatr Infect Dis J; 2020 May; 39(5):460-465. PubMed ID: 31990891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the introduction of rotavirus vaccination on paediatric hospital admissions, Lothian, Scotland: a retrospective observational study.
    Forrest R; Jones L; Willocks L; Hardie A; Templeton K
    Arch Dis Child; 2017 Apr; 102(4):323-327. PubMed ID: 27806968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation.
    Fisman DN; Chan CH; Lowcock E; Naus M; Lee V
    Vaccine; 2012 Dec; 30(52):7601-7. PubMed ID: 23107595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence of severe rotavirus gastroenteritis in children younger than three years of age before and after the introduction of rotavirus vaccine: a prospective observational study in four pediatric clinics in Shibata City, Niigata Prefecture, Japan.
    Oishi T; Matsunaga M; Nakano T; Sudo S; Kuwajima H; Tokuriki S; Study SR
    Hum Vaccin Immunother; 2020 Oct; 16(10):2495-2501. PubMed ID: 32609565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Routine Rotavirus Vaccination in Germany: Evaluation Five Years After Its Introduction.
    Marquis A; Koch J
    Pediatr Infect Dis J; 2020 Jul; 39(7):e109-e116. PubMed ID: 32187139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospital-based surveillance of rotavirus gastroenteritis in the era of limited vaccine uptake through the private sector.
    Trimis G; Koutsoumbari I; Kottaridi C; Palaiologou N; Assimakopoulou E; Spathis A; Lebessi E; Konstantopoulos A; Kafetzis D; Karakitsos P; Papaevangelou V
    Vaccine; 2011 Oct; 29(43):7292-5. PubMed ID: 21816195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First year experience of rotavirus immunisation programme in Finland.
    Leino T; Ollgren J; Salo H; Tiihonen P; Kilpi T
    Vaccine; 2012 Dec; 31(1):176-82. PubMed ID: 23122991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rotavirus vaccines in Israel: Uptake and impact.
    Muhsen K; Cohen D
    Hum Vaccin Immunother; 2017 Jul; 13(7):1722-1727. PubMed ID: 28281866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
    Banajeh SM; Abu-Asba BA
    BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.
    Hemming M; Räsänen S; Huhti L; Paloniemi M; Salminen M; Vesikari T
    Eur J Pediatr; 2013 Jun; 172(6):739-46. PubMed ID: 23361964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.
    Clarke MF; Davidson GP; Gold MS; Marshall HS
    Vaccine; 2011 Jun; 29(29-30):4663-7. PubMed ID: 21575665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
    Feikin DR; Laserson KF; Ojwando J; Nyambane G; Ssempijja V; Audi A; Nyakundi D; Oyieko J; Dallas MJ; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A52-60. PubMed ID: 22520137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.